- Home
- HTLD vs KALV Comparison
HTLD vs KALV Comparison
Compare HTLD & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTLD
- KALV
- Stock Information
- Founded
- HTLD 1978
- KALV N/A
- Country
- HTLD United States
- KALV United States
- Employees
- HTLD N/A
- KALV N/A
- Industry
- HTLD Trucking Freight/Courier Services
- KALV Biotechnology: Pharmaceutical Preparations
- Sector
- HTLD Industrials
- KALV Health Care
- Exchange
- HTLD Nasdaq
- KALV Nasdaq
- Market Cap
- HTLD 685.0M
- KALV 642.3M
- IPO Year
- HTLD N/A
- KALV N/A
- Fundamental
- Price
- HTLD $9.22
- KALV $14.31
- Analyst Decision
- HTLD Sell
- KALV Strong Buy
- Analyst Count
- HTLD 4
- KALV 9
- Target Price
- HTLD $9.75
- KALV $26.29
- AVG Volume (30 Days)
- HTLD 458.8K
- KALV 2.0M
- Earning Date
- HTLD 07-22-2025
- KALV 07-10-2025
- Dividend Yield
- HTLD 0.84%
- KALV N/A
- EPS Growth
- HTLD N/A
- KALV N/A
- EPS
- HTLD N/A
- KALV N/A
- Revenue
- HTLD $996,611,000.00
- KALV N/A
- Revenue This Year
- HTLD N/A
- KALV N/A
- Revenue Next Year
- HTLD $7.04
- KALV $347.19
- P/E Ratio
- HTLD N/A
- KALV N/A
- Revenue Growth
- HTLD N/A
- KALV N/A
- 52 Week Low
- HTLD $7.11
- KALV $7.30
- 52 Week High
- HTLD $13.67
- KALV $16.32
- Technical
- Relative Strength Index (RSI)
- HTLD 57.24
- KALV 58.58
- Support Level
- HTLD $8.90
- KALV $11.10
- Resistance Level
- HTLD $9.66
- KALV $16.32
- Average True Range (ATR)
- HTLD 0.27
- KALV 1.10
- MACD
- HTLD 0.06
- KALV 0.36
- Stochastic Oscillator
- HTLD 64.52
- KALV 68.95
About HTLD Heartland Express Inc.
Heartland Express Inc is engaged in providing truckload services across the United States, Mexico, and Canada. These truckload services are asset-based transportation services in the dry van truckload market. The company offers truckload temperature-controlled transportation services, and Mexico logistics services. A majority of its customers represent the consumer goods, appliances, food products, and automotive industries.
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.